Emergence and dissemination of clade 2.3.4.4 H5Nx influenza viruses — how is the Asian HPAI H5 lineage maintained-Reference-Cited by-同舟云学术

Emergence and dissemination of clade 2.3.4.4 H5Nx influenza viruses — how is the Asian HPAI H5 lineage maintained

Published:2016-02 Issue: Volume:16 Page:158-163
ISSN:1879-6257
Container-title:Current Opinion in Virology
language:en
Short-container-title:Current Opinion in Virology

Author:

Claes Filip,Morzaria Subhash P,Donis Ruben O

Publisher

Elsevier BV

Subject

Virology

Reference39 articles.

1. Nomenclature updates resulting from the evolution of avian influenza A(H5) virus clades 2.1.3.2a, 2.2.1, and 2.3.4 during 2013-2014;Donis;Influenza Other Resp Viruses,2015

2. Reassortant highly pathogenic influenza A(H5N6) virus in Laos;Wong;Emerg Infect Dis,2015

3. Whole-genome sequence of a reassortant H5N6 avian influenza virus isolated from a live poultry market in China, 2013;Qi;Genome Announ,2014

4. Novel reassortant influenza A(H5N8) viruses among inoculated domestic and wild ducks, South Korea, 2014;Kang;Emerg Infect Dis,2015

5. Fatal H5N6 avian influenza virus infection in a domestic cat and wild birds in China;Yu;Sci Rep,2015

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution and Spread of Highly Pathogenic Avian Influenza A(H5N1) Clade 2.3.4.4b Virus in Wild Birds, South Korea, 2022–2023;Emerging Infectious Diseases;2024-02

2. Highly Pathogenic Avian Influenza A(H5N1) Virus–Induced Mass Death of Wild Birds, Caspian Sea, Russia, 2022;Emerging Infectious Diseases;2023-12

3. Challenges for Precise Subtyping and Sequencing of a H5N1 Clade 2.3.4.4b Highly Pathogenic Avian Influenza Virus Isolated in Japan in the 2022–2023 Season Using Classical Serological and Molecular Methods;Viruses;2023-11-18

4. Baloxavir marboxil use for critical human infection of avian influenza A H5N6 virus;2023-09-05

5. Immunogenicity and Cross-Protective Efficacy Induced by an Inactivated Recombinant Avian Influenza A/H5N1 (Clade 2.3.4.4b) Vaccine against Co-Circulating Influenza A/H5Nx Viruses;Vaccines;2023-08-22